Melissa B. Davis

3.5k total citations
84 papers, 1.2k citations indexed

About

Melissa B. Davis is a scholar working on Cancer Research, Oncology and Genetics. According to data from OpenAlex, Melissa B. Davis has authored 84 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Cancer Research, 35 papers in Oncology and 22 papers in Genetics. Recurrent topics in Melissa B. Davis's work include Cancer Genomics and Diagnostics (20 papers), BRCA gene mutations in cancer (15 papers) and Breast Cancer Treatment Studies (15 papers). Melissa B. Davis is often cited by papers focused on Cancer Genomics and Diagnostics (20 papers), BRCA gene mutations in cancer (15 papers) and Breast Cancer Treatment Studies (15 papers). Melissa B. Davis collaborates with scholars based in United States, United Kingdom and Ghana. Melissa B. Davis's co-authors include Lisa A. Newman, Rachel Martini, Clayton Yates, A.E. Robertson, Michael Bender, Ginger E. Carney, Brittany D. Jenkins, Windy Dean‐Colomb, Shalini Srivastava and Qinghua He and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Melissa B. Davis

82 papers receiving 1.2k citations

Peers

Melissa B. Davis
Thomas Krahn Germany
Keith Miller United States
Charles Warden United States
Nikolay Oskolkov Sweden
Apostolos Dimitromanolakis Canada
Bob D. Brown United States
Randi Hovland Norway
J H Todd United States
Ying Tong China
Jennifer Law Canada
Thomas Krahn Germany
Melissa B. Davis
Citations per year, relative to Melissa B. Davis Melissa B. Davis (= 1×) peers Thomas Krahn

Countries citing papers authored by Melissa B. Davis

Since Specialization
Citations

This map shows the geographic impact of Melissa B. Davis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Melissa B. Davis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Melissa B. Davis more than expected).

Fields of papers citing papers by Melissa B. Davis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Melissa B. Davis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Melissa B. Davis. The network helps show where Melissa B. Davis may publish in the future.

Co-authorship network of co-authors of Melissa B. Davis

This figure shows the co-authorship network connecting the top 25 collaborators of Melissa B. Davis. A scholar is included among the top collaborators of Melissa B. Davis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Melissa B. Davis. Melissa B. Davis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Alsaleem, Mansour, Emad A. Rakha, Sheeba Irshad, et al.. (2025). Cardiotoxicity of breast cancer drug treatments. Translational Oncology. 55. 102352–102352. 2 indexed citations
2.
Davis, Melissa B., et al.. (2025). Precision oncology and genetic ancestry: The science behind population-based cancer disparities. Cancer Cell. 43(4). 619–622. 3 indexed citations
3.
Baraban, Ezra, Tamara L. Lotan, Emmanuel S. Antonarakis, et al.. (2024). Abstract 7467: Multi-omics analysis reveals high chronic inflammation in African Americans compared to Native African Men with prostate cancer. Cancer Research. 84(6_Supplement). 7467–7467.
4.
Jenkins, Brittany D., Sandeep K. Singhal, Kevin Gardner, et al.. (2023). Immune Profile of Exosomes in African American Breast Cancer Patients Is Mediated by Kaiso/THBS1/CD47 Signaling. Cancers. 15(8). 2282–2282. 3 indexed citations
5.
Chen, Yalei, Jennifer L. Marti, Rache M. Simmons, et al.. (2023). Survival Outcomes in Women with Unilateral, Triple-Negative, Breast Cancer Correlated with Contralateral Prophylactic Mastectomy. Annals of Surgical Oncology. 30(8). 4648–4656. 5 indexed citations
6.
Telesford, Kiel M., Marcel Mettlen, Melissa B. Davis, et al.. (2023). Neuron-binding antibody responses are associated with Black ethnicity in multiple sclerosis during natalizumab treatment. Brain Communications. 5(4). fcad218–fcad218. 1 indexed citations
7.
Iyer, Hari S., Nur Zeinomar, Angela R. Omilian, et al.. (2023). Neighborhood Disadvantage, African Genetic Ancestry, Cancer Subtype, and Mortality Among Breast Cancer Survivors. JAMA Network Open. 6(8). e2331295–e2331295. 11 indexed citations
8.
Noch, Evan, Yuqing Qiu, Hiranmayi Ravichandran, et al.. (2023). Insulin feedback is a targetable resistance mechanism of PI3K inhibition in glioblastoma. Neuro-Oncology. 25(12). 2165–2176. 18 indexed citations
9.
Roberts, Lewis R., Brian M. Rivers, Clayton Yates, et al.. (2022). Unmet Needs in Oncology Clinical Research and Treatment in Africa: Focus on Ghana. The Oncologist. 27(9). 760–767. 7 indexed citations
10.
11.
Angajala, Anusha, Aliyu Muhammad, Honghe Wang, et al.. (2022). MicroRNAs within the Basal-like signature of Quadruple Negative Breast Cancer impact overall survival in African Americans. Scientific Reports. 12(1). 22178–22178. 4 indexed citations
12.
Zhou, Yi, Shannon Quinn, Melissa B. Davis, et al.. (2021). Are we there yet? A machine learning architecture to predict organotropic metastases. BMC Medical Genomics. 14(1). 281–281. 1 indexed citations
13.
Newman, Lisa A., Laura Fejerman, Tuya Pal, et al.. (2021). Breast Cancer Disparities Through the Lens of the COVID-19 Pandemic. Current Breast Cancer Reports. 13(3). 110–112. 11 indexed citations
14.
Leong, Stanley P. L., Isaac P. Witz, Orit Sagi‐Assif, et al.. (2021). Cancer microenvironment and genomics: evolution in process. Clinical & Experimental Metastasis. 39(1). 85–99. 9 indexed citations
15.
Byun, Jung S., Sandeep K. Singhal, Alana Jones, et al.. (2020). Racial Differences in the Association Between Luminal Master Regulator Gene Expression Levels and Breast Cancer Survival. Clinical Cancer Research. 26(8). 1905–1914. 17 indexed citations
16.
Davis, Melissa B., et al.. (2020). Cancer stem cells: Culprits in endocrine resistance and racial disparities in breast cancer outcomes. Cancer Letters. 500. 64–74. 9 indexed citations
17.
Srivastava, Shalini, et al.. (2017). Antiproliferative Activity of Crocin Involves Targeting of Microtubules in Breast Cancer Cells. Scientific Reports. 7(1). 44984–44984. 59 indexed citations
18.
19.
Davis, Melissa B., Ginger E. Carney, A.E. Robertson, & Michael Bender. (2005). Phenotypic analysis of EcR-A mutants suggests that EcR isoforms have unique functions during Drosophila development. Developmental Biology. 282(2). 385–396. 77 indexed citations
20.
Davis, Melissa B. & Kevin P. White. (2004). Recent advances in Drosophila genomics.. Genome Biology. 5(8). 339–339. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Thomas Krahn Breakdown of academic impact, for papers by Keith Miller Breakdown of academic impact, for papers by Charles Warden Breakdown of academic impact, for papers by Nikolay Oskolkov Breakdown of academic impact, for papers by Apostolos Dimitromanolakis Breakdown of academic impact, for papers by Bob D. Brown Breakdown of academic impact, for papers by Randi Hovland Breakdown of academic impact, for papers by J H Todd Breakdown of academic impact, for papers by Ying Tong Breakdown of academic impact, for papers by Jennifer Law
Rankless by CCL
2026